Frailty in heart failure

被引：80

作者：

Uchmanowicz I. ^{[1
]}

Łoboz-Rudnicka M. ^{[2
]}

Szeląg P. ^{[2
]}

Jankowska-Polańska B. ^{[1
]}

Łoboz-Grudzień K. ^{[2
]}

机构：

[1] Department of Clinical Nursing, Wroclaw Medical University, 51-616 Wroclaw

[2] Department of Cardiology, T. Marciniak Memorial Hospital, Wroclaw

来源：

Current Heart Failure Reports | 2014年 / 11卷 / 3期

关键词：

Cachexia; Comorbidities; Frailty; Heart failure; Prognosis; Sarcopenia;

D O I：

10.1007/s11897-014-0198-4

中图分类号：

学科分类号：

摘要：

Considering the increasing age of individuals affected with heart failure (HF), a specific approach to their treatment is required, with more attention paid to geriatric conditions such as poor mobility, multiple disabilities, and cognitive impairment. Frailty is a distinct biological syndrome reflecting decreased physiologic reserve and resistance to stressors. It was shown to occur frequently in patients with heart failure, with the prevalence ranging from 15 to 74 %, depending on the studied population and the method of assessment. We reviewed literature data on the influence of frailty, skeletal abnormalities, comorbidities and geriatric condition on diagnosis, treatment, and outcomes in elderly patients with HF. Identification of frailty in patients with HF is important from the clinical point of view, as this condition exerts unfavorable effects on the course of heart failure. Frailty contributes to a higher frequency of visits to emergency departments, hospitalizations, and mortality in patients with HF. Exercise may improve mobility, and nursing support can be implemented to help the patients adhere to medications. Therefore, frail patients should be diagnosed and treated according to available guidelines, and successfully educated about their condition. © 2014 Springer Science+Business Media.

引用

页码：266 / 273

页数：7

共 71 条

[1]

Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Et al., Heart disease and stroke statistics-2013 update: A report from the American Heart Association, Circulation, 127, (2013)

[2]

Chaudhry S.I., Wang Y., Gill T.M., Krumholz H.M., Geriatric conditions and subsequent mortality in older patients with heart failure, J Am Coll Cardiol, 55, pp. 309-316, (2010)

[3]

Morley J.E., Vellas B., Van Kan G.A., Anker S.D., Bauer J.M., Bernabei R., Et al., Frailty consensus: A call to action, J Am Med Dir Assoc, 14, pp. 392-397, (2013)

[4]

Afilalo J., Alexander K.P., Mack M.J., Maurer M.S., Green P., Allen L.A., Et al., Frailty assessment in the cardiovascular care of older adults, J Am Coll Cardiol, 63, pp. 747-762, (2014)

[5]

Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A., Frailty in older adults: Evidence for a phenotype, Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 56, 3, (2001)

[6]

Cacciatore F., Abete P., Mazzella F., Viati L., Della M.D., D'Ambrosio D., Gargiulo G., Testa G., De Santis D., Galizia G., Ferrara N., Rengo F., Frailty predicts long-term mortality in elderly subjects with chronic heart failure, European Journal of Clinical Investigation, 35, 12, pp. 723-730, (2005)

[7]

Lupon J., Gonzalez B., Santaeugenia S., Altimir S., Urrutia A., Mas D., Et al., Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure, Rev Esp Cardiol, 61, pp. 835-842, (2008)

[8]

McNallan S.M., Chamberlain A.M., Gerber Y., Singh M., Kane R.L., Weston S.A., Et al., Measuring frailty in heart failure: A community perspective, Am Heart J, 166, pp. 768-774, (2013)

[9]

Dodson J.A., Chaudhry S.I., Geriatric conditions in heart failure, Curr Cardiovasc Risk Rep, 6, pp. 404-410, (2012)

[10]

De Vries N.M., Staal J.B., Van Ravensberg C.D., Hobbelen J.S., Olde Rikkert M.G., Nijhuis-van Der Sanden M.W., Outcome instruments to measure frailty: A systematic review, Ageing Res Rev, 10, pp. 104-114, (2011)

← 1 2 3 4 5 6 7 8 →